Predictive Study of Serum Endocan for Hemorrhagic Transformation After Reperfusion Therapies in Acute Ischemic Stroke
Clinical trial NCT05228080 · UNKNOWN
Trial details
- NCT number
- NCT05228080
- Sponsor
- Xijing Hospital
- Status
- UNKNOWN
- Study type
- OBSERVATIONAL
- Start date
- 2021-12-01
- Primary completion
- 2022-11-01
- Enrollment
- 100
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.